Author:
Jin Liping,Liu Panpan,Yin Mingzhu,Zhang Mi,Kuang Yehong,Zhu Wu
Funder
National Natural Science Foundation of China
Subject
Dermatology,Molecular Biology,Biochemistry
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of 5‐(1‐benzyl‐1H‐imidazol‐4‐yl)‐1,2,4‐oxadiazole derivatives as novel RIPK1 inhibitors via structure‐based virtual screening;Drug Development Research;2024-07-18
2. The role of RIPK1 in chronic obstructive pulmonary disease;Drug Discovery Today;2024-07
3. Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study;Respiratory Research;2024-02-28
4. Discovery of 4-amino-1,6-dihydro-7H-pyrrolo[2,3-d]pyridazin-7-one derivatives as potential receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors;European Journal of Medicinal Chemistry;2024-02
5. Design, synthesis, and structure–activity relationship studies of 6,7-dihydro-5H-pyrrolo[1,2-b][1,2,4]triazole derivatives as necroptosis inhibitors;RSC Medicinal Chemistry;2024